161 related articles for article (PubMed ID: 38356181)
1. Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability.
Liang WC; Xi H; Sun D; D'Ascenzo L; Zarzar J; Stephens N; Cook R; Li Y; Ye Z; Matsumoto M; Payandeh J; Masureel M; Wu Y
MAbs; 2024; 16(1):2309685. PubMed ID: 38356181
[TBL] [Abstract][Full Text] [Related]
2. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K
MAbs; 2019; 11(4):666-680. PubMed ID: 31046547
[TBL] [Abstract][Full Text] [Related]
3. Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples.
Zhang YF; Ho M
MAbs; 2017 Apr; 9(3):419-429. PubMed ID: 28165915
[TBL] [Abstract][Full Text] [Related]
4. Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody.
Apgar JR; Mader M; Agostinelli R; Benard S; Bialek P; Johnson M; Gao Y; Krebs M; Owens J; Parris K; St Andre M; Svenson K; Morris C; Tchistiakova L
MAbs; 2016 Oct; 8(7):1302-1318. PubMed ID: 27625211
[TBL] [Abstract][Full Text] [Related]
5. Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries.
Azevedo Reis Teixeira A; Erasmus MF; D'Angelo S; Naranjo L; Ferrara F; Leal-Lopes C; Durrant O; Galmiche C; Morelli A; Scott-Tucker A; Bradbury ARM
MAbs; 2021; 13(1):1980942. PubMed ID: 34850665
[TBL] [Abstract][Full Text] [Related]
6. Anti-PD1 'SHR-1210' aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinement.
Finlay WJJ; Coleman JE; Edwards JS; Johnson KS
MAbs; 2019 Jan; 11(1):26-44. PubMed ID: 30541416
[TBL] [Abstract][Full Text] [Related]
7. Matrixed CDR grafting: A neoclassical framework for antibody humanization and developability.
Gupta P; Horspool AM; Trivedi G; Moretti G; Datar A; Huang ZF; Chiecko J; Kenny CH; Marlow MS
J Biol Chem; 2024 Jan; 300(1):105555. PubMed ID: 38072062
[TBL] [Abstract][Full Text] [Related]
8. The functional repertoire of rabbit antibodies and antibody discovery via next-generation sequencing.
Kodangattil S; Huard C; Ross C; Li J; Gao H; Mascioni A; Hodawadekar S; Naik S; Min-debartolo J; Visintin A; Almagro JC
MAbs; 2014; 6(3):628-36. PubMed ID: 24481222
[TBL] [Abstract][Full Text] [Related]
9. Antibody humanization by structure-based computational protein design.
Choi Y; Hua C; Sentman CL; Ackerman ME; Bailey-Kellogg C
MAbs; 2015; 7(6):1045-57. PubMed ID: 26252731
[TBL] [Abstract][Full Text] [Related]
10. Landscape of Non-canonical Cysteines in Human V
Prabakaran P; Chowdhury PS
Cell Rep; 2020 Jun; 31(13):107831. PubMed ID: 32610132
[TBL] [Abstract][Full Text] [Related]
11. Generic approach for the generation of stable humanized single-chain Fv fragments from rabbit monoclonal antibodies.
Borras L; Gunde T; Tietz J; Bauer U; Hulmann-Cottier V; Grimshaw JP; Urech DM
J Biol Chem; 2010 Mar; 285(12):9054-66. PubMed ID: 20056614
[TBL] [Abstract][Full Text] [Related]
12. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
[TBL] [Abstract][Full Text] [Related]
13. Optimizing Antibody Affinity and Developability Using a Framework-CDR Shuffling Approach-Application to an Anti-SARS-CoV-2 Antibody.
Gopal R; Fitzpatrick E; Pentakota N; Jayaraman A; Tharakaraman K; Capila I
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560698
[TBL] [Abstract][Full Text] [Related]
14. Use of human germline genes in a CDR homology-based approach to antibody humanization.
Hwang WY; Almagro JC; Buss TN; Tan P; Foote J
Methods; 2005 May; 36(1):35-42. PubMed ID: 15848073
[TBL] [Abstract][Full Text] [Related]
15. High-Resolution IMS-MS to Assign Additional Disulfide Bridge Pairing in Complementarity-Determining Regions of an IgG4 Monoclonal Antibody.
Deslignière E; Botzanowski T; Diemer H; Cooper-Shepherd DA; Wagner-Rousset E; Colas O; Béchade G; Giles K; Hernandez-Alba O; Beck A; Cianférani S
J Am Soc Mass Spectrom; 2021 Oct; 32(10):2505-2512. PubMed ID: 34437803
[TBL] [Abstract][Full Text] [Related]
16. A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining Regions.
Maruthachalam BV; El-Sayed A; Liu J; Sutherland AR; Hill W; Alam MK; Pastushok L; Fonge H; Barreto K; Geyer CR
Chembiochem; 2017 Nov; 18(22):2247-2259. PubMed ID: 28884521
[TBL] [Abstract][Full Text] [Related]
17. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
[TBL] [Abstract][Full Text] [Related]
19. SDR grafting--a new approach to antibody humanization.
Kashmiri SV; De Pascalis R; Gonzales NR; Schlom J
Methods; 2005 May; 36(1):25-34. PubMed ID: 15848072
[TBL] [Abstract][Full Text] [Related]
20. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
